Company press releases

Displaying 1 - 50 of 94 results
Released Company Title Industry Topic
29 Mar 2024
18:02 CET 		EQUASENS Equasens: 2023 Annual Results 10101015 Software Income
29 Mar 2024
18:02 CET 		EQUASENS EQUASENS : Résultats Annuels 2023 10101015 Software Income
07 Feb 2024
18:30 CET 		EQUASENS EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE 10101015 Software Other subject
06 Feb 2024
18:00 CET 		EQUASENS Equasens: 2023 revenue: €219.7m, +2.6% 10101015 Software Sales
06 Feb 2024
18:00 CET 		EQUASENS EQUASENS : Chiffre d’affaires 2023 : +2,6 % à 219,7 M€ 10101015 Software Sales
02 Jan 2024
18:00 CET 		EQUASENS Equasens: Acquisition of a majority stake in DIGIPHARMACIE 10101015 Software Mergers, Acquiqitions, Transferts
02 Jan 2024
18:00 CET 		EQUASENS EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE 10101015 Software Mergers, Acquiqitions, Transferts
27 Dec 2023
18:00 CET 		EQUASENS Equasens: Changes in the Equasens Group Executive Committee 10101015 Software Journal / appointments
27 Dec 2023
18:00 CET 		EQUASENS EQUASENS : Evolution du Comité de Direction du Groupe Equasens 10101015 Software Journal / appointments
23 Nov 2023
18:00 CET 		EQUASENS EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany 10101015 Software Mergers, Acquiqitions, Transferts
23 Nov 2023
18:00 CET 		EQUASENS EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany 10101015 Software Mergers, Acquiqitions, Transferts
09 Nov 2023
18:00 CET 		EQUASENS EQUASENS : Chiffre d’affaires du 3ème trimestre 2023 10101015 Software Sales
09 Nov 2023
18:00 CET 		EQUASENS Equasens: Q3 2023 revenue 10101015 Software Sales
04 Oct 2023
18:06 CEST 		EQUASENS EQUASENS : Mise à disposition du Rapport Financier Semestriel 2023 10101015 Software Income
29 Sep 2023
18:00 CEST 		EQUASENS EQUASENS: H1 2023 Results 10101015 Software Income
29 Sep 2023
18:00 CEST 		EQUASENS EQUASENS : Résultats Semestriels 2023 10101015 Software Income
25 Sep 2023
18:00 CEST 		EQUASENS EQUASENS : bilan du contrat de liquidité au 30 juin 2023 10101015 Software Other subject
03 Aug 2023
18:00 CEST 		EQUASENS GROUPE EQUASENS : Chiffre d’affaires du 1er semestre 2023 en progression de 9 % à 112,62 M€ 10101015 Software Sales
03 Aug 2023
18:00 CEST 		EQUASENS EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m 10101015 Software Sales
05 Jul 2023
18:00 CEST 		EQUASENS EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023 10101015 Software General meeting / Board Meeting
05 Jul 2023
18:00 CEST 		EQUASENS EQUASENS : résultat du vote des résolutions présentées à l’assemblée générale ordinaire annuelle du 29 juin 2023 10101015 Software General meeting / Board Meeting
09 Jun 2023
18:00 CEST 		EQUASENS EQUASENS: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS 10101015 Software General meeting / Board Meeting
09 Jun 2023
18:00 CEST 		EQUASENS EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES 10101015 Software General meeting / Board Meeting
11 May 2023
18:00 CEST 		EQUASENS EQUASENS: Q1 2023 revenue: +13.96% to €56.25m 10101015 Software Sales
11 May 2023
18:00 CEST 		EQUASENS EQUASENS : Chiffre d’affaires T1 2023 : +13,96% à 56,25 M€ 10101015 Software Sales
04 May 2023
12:00 CEST 		EQUASENS EQUASENS : Mise à disposition du Document d’Enregistrement Universel 2022 10101015 Software Other subject
06 Apr 2023
18:00 CEST 		EQUASENS EQUASENS : Atoopharm, le spécialiste e-learning de la formation officinale, rejoint le Groupe Equasens. 10101015 Software Mergers, Acquiqitions, Transferts
03 Apr 2023
07:00 CEST 		EQUASENS EQUASENS : Acquisitions de Pratilog et Speech2Sense 10101015 Software Mergers, Acquiqitions, Transferts
24 Mar 2023
18:00 CET 		EQUASENS EQUASENS: 2022 Net Profit: +18.35% to €48.70m 10101015 Software Income
24 Mar 2023
18:00 CET 		EQUASENS EQUASENS : Résultat Net 2022 : +18,35% à 48,70 M€ 10101015 Software Income
03 Feb 2023
18:00 CET 		EQUASENS EQUASENS: FY 2022 revenue: +10.88% to €214.07m 10101015 Software Sales
03 Feb 2023
18:00 CET 		EQUASENS EQUASENS : CA 2022 : +10,88% à 214,07 M€ 10101015 Software Sales
20 Jan 2023
18:00 CET 		EQUASENS EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT 10101015 Software Share history
20 Jan 2023
18:00 CET 		EQUASENS EQUASENS : BILAN SEMESTRIEL S2-2022 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC GILBERT DUPONT 10101015 Software Share history
19 Jan 2023
18:00 CET 		EQUASENS EQUASENS: Appointment of Frédérique SCHMIDT as the Group’s Chief Administrative and Financial Officer 10101015 Software Journal / appointments
19 Jan 2023
18:00 CET 		EQUASENS EQUASENS : Nomination de Frédérique SCHMIDT en tant que Directrice Administrative et Financière du Groupe 10101015 Software Journal / appointments
09 Nov 2022
18:00 CET 		EQUASENS GROUPE EQUASENS : Chiffre d’affaires du 3ème trimestre 2022 10101015 Software Sales
09 Nov 2022
18:00 CET 		EQUASENS EQUASENS GROUP: 2022 third-quarter revenue 10101015 Software Sales
18 Oct 2022
18:00 CEST 		EQUASENS EQUASENS : sa filiale PANDALAB certifié ISO 27001 et HDS   10101015 Software Corporate life
18 Oct 2022
18:00 CEST 		EQUASENS EQUASENS: subsidiary PANDALAB receives ISO 27001 and HDS certifications 10101015 Software Corporate life
30 Sep 2022
18:00 CEST 		EQUASENS EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2022 10101015 Software Income
22 Sep 2022
18:00 CEST 		EQUASENS EQUASENS: H1 2022 Results 10101015 Software Income
22 Sep 2022
18:00 CEST 		EQUASENS EQUASENS : Résultats Semestriels 2022 10101015 Software Income
03 Aug 2022
18:00 CEST 		EQUASENS EQUASENS (ex-PHARMAGEST INTERACTIVE) : Chiffre d’affaires du 1er semestre 2022 10101015 Software Sales
03 Aug 2022
18:00 CEST 		EQUASENS EQUASENS (ex-Pharmagest Interactive): H1 2022 Revenue 10101015 Software Sales
28 Jul 2022
18:00 CEST 		EQUASENS EQUASENS (ex - PHARMAGEST INTERACTIVE) : Le Groupe complète 3 prises de participation majoritaire 10101015 Software Mergers, Acquiqitions, Transferts
28 Jul 2022
18:00 CEST 		EQUASENS Equasens Group (ex Pharmagest Interactive): Complition of three majority acquisitions 10101015 Software Mergers, Acquiqitions, Transferts
21 Jul 2022
18:00 CEST 		EQUASENS EQUASENS (ex PHARMAGEST INTERACTIVE) : BILAN SEMESTRIEL S1-2022 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT 10101015 Software Other subject
21 Jul 2022
18:00 CEST 		EQUASENS EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT 10101015 Software Other subject
06 Jul 2022
19:01 CEST 		EQUASENS EQUASENS (ex Pharmagest Interactive) : RESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DU 28 JUIN 2022 10101015 Software General meeting / Board Meeting